Kingsview Wealth Management, LLC

Position in INCY — Incyte Corp

CIK 1791965 GRANTS PASS, OR

Position in INCY

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$294,972

-$161,245 QoQ

Shares Held

3,134

-44.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Kingsview Wealth Management, LLC holds $3,730,947 across 13 Biotechnology names. INCY ranks #6 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	21,975	$715,066
2	IMRX	Immuneering Corp	122,200	$643,994
3	REGN	Regeneron Pharmaceuticals, Inc.	739	$570,980
4	INSM	INSMED Inc	2,089	$341,593
5	AXSM	Axsome Therapeutics, Inc.	1,806	$305,250
6	INCY	Incyte Corp This page	3,134	$294,972
7	VRTX	Vertex Pharmaceuticals Inc / Ma	545	$243,364
8	TRVI	Trevi Therapeutics, Inc.	15,770	$188,136

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$294,972	3,134	-44.8%	Shares	Sole	2026-05-12
2022-12-31	$456,217	5,680	+109.7%	Shares	Sole	2023-02-13
2022-06-30	$205,802	2,709	+0.7%	Shares	Sole	2022-08-16
2022-03-31	$213,560	2,689	-29.2%	Shares	Sole	2024-02-08
2021-12-31	$278,626	3,796	+21.8%	Shares	Sole	2022-02-17
2021-09-30	$214,318	3,116	-1.6%	Shares	Sole	2021-12-03
2021-06-30	$266,355	3,166	-8.7%	Shares	Sole	2021-08-17
2021-03-31	$281,681	3,466	-9.8%	Shares	Sole	2021-05-24
2020-12-31	$334,090	3,841	-0.8%	Shares	Sole	2021-02-16
2020-09-30	$347,383	3,871	+11.4%	Shares	Sole	2020-11-19
2020-06-30	$361,295	3,475	-5.4%	Shares	Sole	2020-08-14
2020-03-31	$269,120	3,675	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.